Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Natural Health Trends (NHTC) Cash & Equivalents: 2010-2024

Historic Cash & Equivalents for Natural Health Trends (NHTC) over the last 15 years, with FY2024 value amounting to $13.5 million.

  • Natural Health Trends' Cash & Equivalents fell 3749.84% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year decrease of 3749.84%. This contributed to the annual value of $13.5 million for FY2024, which is 7592.72% down from last year.
  • Per Natural Health Trends' latest filing, its Cash & Equivalents stood at $13.5 million for FY2024, which was down 7592.72% from $56.2 million recorded in FY2023.
  • In the past 5 years, Natural Health Trends' Cash & Equivalents ranged from a high of $92.9 million in FY2020 and a low of $13.5 million during FY2024
  • Its 5-year average for Cash & Equivalents is $63.4 million, with a median of $69.7 million in 2022.
  • In the last 5 years, Natural Health Trends' Cash & Equivalents tumbled by 657.08% in 2020 and then plummeted by 7592.72% in 2024.
  • Over the past 5 years, Natural Health Trends' Cash & Equivalents (Annual) stood at $92.9 million in 2020, then decreased by 9.18% to $84.4 million in 2021, then decreased by 17.33% to $69.7 million in 2022, then dropped by 19.4% to $56.2 million in 2023, then tumbled by 75.93% to $13.5 million in 2024.
  • Its Cash & Equivalents stands at $13.5 million for FY2024, versus $56.2 million for FY2023 and $69.7 million for FY2022.